News
-
-
-
-
PRESS RELEASE
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines, a clinical-stage biopharmaceutical company focused on developing cancer therapies. Parabilis IPO marks significant milestone in biotechnology sector -
-
-
-
-
-